Axim Planning & Wealth Buys Shares of 6,959 Colgate-Palmolive Company $CL

Axim Planning & Wealth purchased a new position in Colgate-Palmolive Company (NYSE:CL) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 6,959 shares of the company’s stock, valued at approximately $556,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Asset Management One Co. Ltd. raised its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after acquiring an additional 16,017 shares during the last quarter. Cidel Asset Management Inc. raised its position in Colgate-Palmolive by 13.6% during the 2nd quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after purchasing an additional 39,413 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Colgate-Palmolive by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after buying an additional 993,432 shares during the period. TD Waterhouse Canada Inc. grew its position in shares of Colgate-Palmolive by 248.5% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after buying an additional 62,327 shares during the last quarter. Finally, Sequoia Financial Advisors LLC increased its stake in shares of Colgate-Palmolive by 18.6% during the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock valued at $2,752,000 after buying an additional 4,738 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a report on Sunday, February 1st. Raymond James Financial cut their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Finally, Morgan Stanley increased their target price on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research report on Monday. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $94.47.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $94.48 on Friday. The company has a 50 day simple moving average of $82.13 and a two-hundred day simple moving average of $81.65. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company has a market capitalization of $76.16 billion, a price-to-earnings ratio of 36.06, a P/E/G ratio of 4.29 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 79.39%.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.